Past News

University professors rev up efforts to commercialize research, launch startups

October 30, 2020

One thought on “University professors rev up efforts to commercialize research, launch startups”

University professors rev up efforts to commercialize research, launch startups

https://www.news-medical.net/news/20201030/Time-machine-suggests-a-drug-testing-approach-for-pancreatic-cancer.aspx

October 30, 2020

Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated.

https://www.news-medical.net/news/20201030/Time-machine-suggests-a-drug-testing-approach-for-pancreatic-cancer.aspx

Microfluidic Device to Test Pancreatic Cancer Drugs

October 30, 2020

Certain varieties of pancreatic cancer exhibit multiple tumor cell subtypes that work, somewhat mysteriously, to quickly become resistant to chemotherapy agents. Researchers at Purdue University have now built a unique microfluidic device that can be used to test a cancer drug on multiple tumor cells subtypes. Using this technology the researchers believe that new drug therapies can be discovered and existing medicines used more effectively.

Microfluidic Device to Test Pancreatic Cancer Drugs

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

October 29, 2020

Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated.

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

Purdue Battles Higher Rate of Alzheimer’s in Soldiers with $1.3M Grant

October 29, 2020

https://www.insideindianabusiness.com/story/42837191/purdue-battles-higher-rate-of-alzheimers-in-soldiers-with-dollar13m-grant

Purdue Battles Higher Rate of Alzheimer’s in Soldiers with $1.3M Grant

'Time machine' offers new pancreatic cancer drug testing approach

October 29, 2020

Many patients with pancreatic cancer have only about a 10% chance of survival within five years of their diagnosis because they tend to become resistant to chemotherapy, past studies have indicated.

'Time machine' offers new pancreatic cancer drug testing approach

Purdue Battles Higher Rate of Alzheimer’s in Soldiers with $1.3M Grant

October 29, 2020

Soldiers are suffering long after the battlefield; the U.S. military’s suicide rate is at an all-time high, surpassing combat deaths since 2012. Soldiers are two to four times more likely to develop Alzheimer’s disease than civilians, and military families suffer emotional trauma when depression, memory loss and aggression alter the soldier they knew before deployment. A Purdue University researcher says “as a society that collectively enjoys the freedoms ensured by their sacrifices, [we] are facing a moral obligation in a race against time to save these men and women.” A $1.3 million grant from the Department of Defense aims to use the power of scientific weaponry to uncover the link between the battlefield and neurodegeneration.

Purdue Battles Higher Rate of Alzheimer’s in Soldiers with $1.3M Grant

New 3-D cell culture method points to personalized cancer therapies

October 29, 2020

Each cancer patient's tumors have cells that look and act differently, making it difficult for scientists to determine treatments based on tumors grown from generic cell cultures in the lab.

New 3-D cell culture method points to personalized cancer therapies

Does a Video Show a ‘Butthole’ Surfing Robot?

October 29, 2020

In October 2020, microscopic robots that could “effortlessly surf right up your butthole” made headlines after engineers at Purdue University announced that they had developed a “microrobot” capable of delivering pharmaceutical drugs to vital organs by gaining entry through the rectum.

Does a Video Show a ‘Butthole’ Surfing Robot?

Professor models novel coronavirus proteins with the help of ITaP supercomputers

October 28, 2020

Daisuke Kihara, a professor of biological sciences and computer science, has used Purdue’s supercomputers to develop computational models of the proteins in the novel coronavirus SARS-CoV-2 that may prove useful for the development of drugs to treat COVID-19.

Professor models novel coronavirus proteins with the help of ITaP supercomputers